Article
Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review.
Pediatric research - 1 Jan 2018
Simones Ann A, Beisang Daniel J, Panoskaltsis-Mortari Angela, Roberts Kari D
Abstract excerpt
Advances in neonatal medicine have led to increased survival of infants born at the limits of viability, resulting in an increased incidence of bronchopulmonary dysplasia (BPD). BPD is a chronic lung disease of premature infants characterized by the arrest of alveolarization, fibroblast activation, and inflammation. BPD leads to significant morbidity and mortality in the neonatal period and is one of the leading...
Topics
- Animals
- Bronchopulmonary Dysplasia
- Clinical Trials as Topic
- Fibroblasts
- Humans
- Infant
- Infant, Newborn
- Infant, Premature
- Inflammation
- Lung Diseases
- Mesenchymal Stem Cell Transplantation
